Astrazeneca to buy Esobiotec in a billion dollar deal to enhance the ambition of cell therapy (AZN: NASDAQ)

Esobiotec SA entered into a final agreement to be acquired By Astrazeneca (Nasdak:TinHe said on Monday that up to one billion dollars, on the basis of debt cash.

The deal includes a preliminary payment of $ 425 million at closing, and above